0.30 0.00 (0.00%)

New 52W Low today

113.8K XNAS Volume

XNAS 21 Mar, 2025 2:22 PM (EDT)



Insider Trading disclosures for Cyclacel Pharmaceuticals Inc

The latest disclosure was made by David Natan in Cyclacel Pharmaceuticals Inc where a trade of 700,000 Non-Qualified Stock Option (Right to Buy) done was reported to US exchanges on Feb. 26, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
David Natan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 700,000 700,000 - - Non-Qualified Stock Option (Right to Buy)
Avraham Ben-Tzvi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 700,000 700,000 - - Non-Qualified Stock Option (Right to Buy)
David E. Lazar Interim CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2025 1,745,262 354,738 - - Series D Convertible Preferred Stock
David E. Lazar Interim CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2025 2,650,000 2,650,000 (15%) 15% - Common Stock
David E. Lazar Interim CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2025 191,978,820 194,628,820 (999.99%) 1116% - Common Stock
David E. Lazar Interim CEO, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.03 per share. 26 Feb 2025 194,628,820 0 (0%) 1131% 0.0 5,507,996 Common Stock
David E. Lazar Interim CEO, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2025 1,000,000 0 - - Series C Convertible Preferred Stock
David E. Lazar Interim CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2025 2,100,000 2,100,000 - - Series D Convertible Preferred Stock
David Natan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 100,000 100,000 (0%) 0% - Common Stock
Paul McBarron Director, See Remarks 21 Dec 2023 1,886 33,378 (0%) 0% 3.3 6,252 Common Stock
Rombotis Spiro Director, President and CEO 21 Dec 2023 6,070 6,070 - - Warrants (right to buy)
Rombotis Spiro Director, President and CEO 21 Dec 2023 6,070 68,658 (0%) 0% 3.3 20,122 Common Stock
McBarron Paul Director, See Remarks 21 Dec 2023 1,886 1,886 - - Warrants (right to buy)
Christopher S. Henney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 21,219 39,415 (0%) 0% 0 Common Stock
Christopher S. Henney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 42,438 42,438 - - Stock Option (right to buy)
Paul McBarron Director, See Remarks 30 Jun 2023 70,200 70,200 - - Stock Option (right to buy)
Spiro Rombotis Director, President and CEO 30 Jun 2023 110,000 110,000 - - Stock Option (right to buy)
Samuel L. Barker Director 30 Jun 2023 21,219 40,415 (0%) 0% 0 Common Stock
Samuel L. Barker Director 30 Jun 2023 42,438 42,438 - - Stock Option (right to buy)
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 21,219 39,415 (0%) 0% 0 Common Stock
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 42,438 42,438 - - Stock Option (right to buy)
Kenneth M. Ferguson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 42,438 42,438 - - Stock Option (right to buy)
Kenneth M. Ferguson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 21,219 44,952 (0%) 0% 0 Common Stock
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 21,219 40,602 (0%) 0% 0 Common Stock
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 42,438 42,438 - - Stock Option (right to buy)
Mark Kirschbaum Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 70,200 70,200 - - Stock Option (right to buy)
Paul McBarron Director, See Remarks 31 Jan 2023 31,200 31,492 (0%) 0% 0 Common Stock
Spiro Rombotis Director, President and CEO 31 Jan 2023 57,600 62,588 (0%) 0% 0 Common Stock
Mark Kirschbaum Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2023 31,200 31,200 (0%) 0% 0 Common Stock
Christopher S. Henney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 15,822 18,196 (0%) 0% 0 Common Stock
Christopher S. Henney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 31,645 31,645 - - Stock Option (right to buy)
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 31,645 31,645 - - Stock Option (right to buy)
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 15,822 18,196 (0%) 0% 0 Common Stock
Samuel L. Barker Director 14 Jun 2022 15,822 19,196 (0%) 0% 0 Common Stock
Samuel L. Barker Director 14 Jun 2022 31,645 31,645 - - Stock Option (right to buy)
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 15,822 18,196 (0%) 0% 0 Common Stock
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 31,645 31,645 - - Stock Option (right to buy)
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 31,645 31,645 - - Stock Option (right to buy)
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 15,822 19,383 (0%) 0% 0 Common Stock
Paul McBarron Director, See Remarks 13 Dec 2021 100,000 100,000 - - Stock Option (right to buy)
Spiro Rombotis Director, President and CEO 13 Dec 2021 190,000 190,000 - - Stock Option (right to buy)
Mark Kirschbaum Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2021 100,000 100,000 - - Stock Option (right to buy)
Samuel L. Barker Director 30 Nov 2021 12 3,374 (0%) 0% 3.6 43 Common Stock
Spiro Rombotis Director, President and CEO 18 Nov 2021 4,000 4,988 (0%) 0% 4.5 18,000 Common Stock
Samuel L. Barker Director 24 Aug 2021 1,000 3,386 (0%) 0% 5 5,000 Common Stock
Christopher S. Henney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,748 4,748 - - Stock Option (right to buy)
Christopher S. Henney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 2,374 2,374 (0%) 0% 0 Common Stock
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 2,374 2,374 (0%) 0% 0 Common Stock
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,748 4,748 - - Stock Option (right to buy)
Samuel L. Barker Director 15 Jun 2021 2,374 2,386 (0%) 0% 0 Common Stock
Samuel L. Barker Director 15 Jun 2021 4,748 4,748 - - Stock Option (right to buy)
Gregory T. Hradsky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,748 4,748 - - Stock Option (right to buy)
Gregory T. Hradsky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 2,374 2,374 (0%) 0% 0 Common Stock
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 2,374 2,374 (0%) 0% 0 Common Stock
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,748 4,748 - - Stock Option (right to buy)
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 2,374 3,561 (0%) 0% 0 Common Stock
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 2,374 7,122 - - Stock Option (right to buy)
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,748 7,122 - - Stock Option (right to buy)
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 1,187 3,561 (0%) 0% 0 Common Stock
Paul McBarron Director, See Remarks 11 Dec 2020 120,000 120,000 - - Stock Option (right to buy)
Spiro Rombotis Director, President and CEO 11 Dec 2020 175,000 175,000 - - Stock Option (right to buy)
Karin L. Walker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2020 5,200 5,200 - - Stock Option (right to buy)
Mark Kirschbaum Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Oct 2020 120,000 120,000 - - Stock Option (right to buy)
Christopher S. Henney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 5,200 5,200 - - Stock Option (right to buy)
Lloyd M. Sems Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 5,200 5,200 - - Stock Option (right to buy)
Samuel L. Barker Director 25 Jun 2020 5,200 5,200 - - Stock Option (right to buy)
John Banham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 5,200 5,200 - - Stock Option (right to buy)
David C. U'Prichard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 5,200 5,200 - - Stock Option (right to buy)
Gregory T. Hradsky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 5,200 5,200 - - Stock Option (right to buy)
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 5,200 5,200 - - Stock Option (right to buy)
Paul McBarron Director, E. VP, Fin, CFO and COO 05 Dec 2019 11,980 11,980 - - Option
Paul McBarron Director, E. VP, Fin, CFO and COO 05 Dec 2019 13,022 13,022 - - Option
Spiro Rombotis Director, President and CEO 05 Dec 2019 15,625 15,625 - - Option
Spiro Rombotis Director, President and CEO 05 Dec 2019 15,625 15,625 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2019 10,182 10,182 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2019 11,067 11,067 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2019 18,750 18,750 - - Stock Option (right to buy)
Lloyd M. Sems None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2019 18,750 18,750 - - Stock Option (right to buy)
Samuel L. Barker None 29 May 2019 18,750 18,750 - - Stock Option (right to buy)
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2019 18,750 18,750 - - Stock Option (right to buy)
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2019 18,750 18,750 - - Stock Option (right to buy)
Gregory T. Hradsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2019 18,750 18,750 - - Stock Option (right to buy)
Robert J. Spiegel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2019 18,750 18,750 - - Stock Option (right to buy)
Paul McBarron Director, E. VP, Fin, CFO and COO 03 Jan 2019 13,021 13,021 - - Option
Paul McBarron Director, E. VP, Fin, CFO and COO 03 Jan 2019 11,980 11,980 - - Option
Paul McBarron Director, E. VP, Fin, CFO and COO 03 Jan 2019 270,079 270,079 - - Option
Spiro Rombotis Director, President and CEO 03 Jan 2019 15,625 15,625 - - Option
Spiro Rombotis Director, President and CEO 03 Jan 2019 508,198 508,198 - - Option
Spiro Rombotis Director, President and CEO 03 Jan 2019 14,375 14,375 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2019 11,068 11,068 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2019 10,183 10,183 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2019 284,592 284,592 - - Option
Robert J. Spiegel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Sep 2018 8,576 8,576 - - Stock Option (right to buy)
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2018 8,576 8,576 - - Stock Option (right to buy)
Lloyd M. Sems None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2018 8,576 8,576 - - Stock Option (right to buy)
Samuel L. Barker None 31 May 2018 8,576 8,576 - - Stock Option (right to buy)
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2018 8,576 8,576 - - Stock Option (right to buy)
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2018 8,576 8,576 - - Stock Option (right to buy)
Gregory T. Hradsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2018 8,576 8,576 - - Stock Option (right to buy)
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2017 2,000 2,000 - - Stock Option (right to buy)
Lloyd M. Sems None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2017 2,000 2,000 - - Stock Option (right to buy)
Samuel L. Barker None 30 May 2017 2,000 2,000 - - Stock Option (right to buy)
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2017 2,000 2,000 - - Stock Option (right to buy)
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2017 2,000 2,000 - - Stock Option (right to buy)
Gregory T. Hradsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2017 2,000 2,000 - - Stock Option (right to buy)
Kevin C. Tang Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.34 per share. 23 Feb 2017 134,200 559,900 (13%) 3% 4.3 582,079 Common Stock
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2016 15,000 15,000 - - Option
Samuel L. Barker None 26 May 2016 15,000 15,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2016 15,000 15,000 - - Option
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2016 15,000 15,000 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2016 15,000 15,000 - - Option
Lloyd M. Sems None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2016 15,000 15,000 - - Option
Gregory T. Hradsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2016 15,000 15,000 - - Option
Paul McBarron Director, E.V.P., Fin, C.F.O. & C.O.O. 07 Dec 2015 260,432 260,432 - - Option
Spiro Rombotis Director, President & C.E.O. 07 Dec 2015 437,569 437,569 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2015 229,858 229,858 - - Option
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2015 15,000 15,000 - - Option
Samuel L. Barker None 22 May 2015 15,000 15,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2015 15,000 15,000 - - Option
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2015 15,000 15,000 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2015 15,000 15,000 - - Option
Lloyd M. Sems None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2015 15,000 15,000 - - Option
Gregory T. Hradsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2015 15,000 15,000 - - Option
Paul McBarron Director, E.V.P.,Finance,C.F.O. & C.O.O. 18 Feb 2015 53,095 53,095 - - Option
Spiro Rombotis Director, President & C.E.O. 18 Feb 2015 81,742 81,742 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2015 42,940 42,940 - - Option
Spiro Rombotis Director, President & CEO 31 Dec 2014 3,891 237,525 - - Common Stock, $0.001 par value per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 31 Dec 2014 3,112 58,008 - - Common Stock, $0.001 par value per share
Samuel L. Barker None 20 Nov 2014 3,100 3,100 - - Common Stock, $0.001 par value per share
Samuel L. Barker None 10 Sep 2014 9,000 9,000 - - Option
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 9,000 9,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 9,000 9,000 - - Option
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 9,000 9,000 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 9,000 9,000 - - Option
Lloyd M. Sems None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 9,000 9,000 - - Option
Gregory T. Hradsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2014 9,000 9,000 - - Option
Paul McBarron Director, E.V.P.,Finance,C.F.O. & C.O.O. 09 Dec 2013 70,000 70,000 - - Option
Spiro Rombotis Director, President & C.E.O. 09 Dec 2013 105,000 105,000 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2013 65,000 65,000 - - Option
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2013 5,000 5,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2013 7,142 7,142 - - Option
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2013 3,571 3,571 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2013 7,142 7,142 - - Option
Lloyd M. Sems None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2013 3,571 3,571 - - Option
Gregory T. Hradsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2013 3,571 3,571 - - Option
Paul McBarron Director, EVP, Finance, CFO, COO 21 May 2013 8,333 65,481 - - Common Stock, $0.001 par value per share
Paul McBarron Director, EVP, Finance, CFO, COO 21 May 2013 4,615 70,096 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President & C.E.O. 21 May 2013 100,000 268,292 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President & C.E.O. 21 May 2013 100,000 241,416 - - Common Stock, $0.001 par value per share
Lloyd M. Sems None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 21 May 2013 33,333 33,333 - - Common Stock, $0.001 par value per share
Paul McBarron Director, EVP, Finance, CFO, COO 25 Jan 2013 6,712 75,433 - - Common Stock, $0.001 par value per share
Paul McBarron Director, EVP, Finance, CFO, COO 25 Jan 2013 20,000 68,721 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President & CEO 25 Jan 2013 10,791 168,292 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President & CEO 25 Jan 2013 20,000 157,501 - - Common Stock, $0.001 par value per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2013 5,668 44,692 - - Common Stock, $0.001 par value per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2013 20,000 39,024 - - Common Stock, $0.001 par value per share
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2012 25,000 25,000 - - Option
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2012 35,000 35,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2012 50,000 50,000 - - Option
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2012 25,000 25,000 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2012 50,000 50,000 - - Option
Lloyd M. Sems None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2012 25,000 25,000 - - Option
Gregory T. Hradsky None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2012 25,000 25,000 - - Option
Spiro Rombotis Director, President & C.E.O. 22 Dec 2011 15,902 746,516 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President & C.E.O. 22 Dec 2011 75,000 730,614 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President & C.E.O. 22 Dec 2011 75,000 0 - - Option
Paul McBarron Director, EVP, Finance, CFO, COO 06 Dec 2011 75,000 263,054 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President & C.E.O. 06 Dec 2011 75,000 655,614 - - Common Stock, $0.001 par value per share
Judy Chiao V.P., Clin. Dev. & reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2011 60,000 133,168 - - Common Stock, $0.001 par value per share
Robert Sosnowski VP, Marketing & Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2011 28,000 28,000 - - Common Stock, $0.001 par value per share
Paul McBarron Director, EVP, Finance, CFO, COO 23 Sep 2011 12,000 188,054 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President and C.E.O. 22 Sep 2011 5,000 584,430 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President and C.E.O. 22 Sep 2011 24,100 608,530 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President and C.E.O. 22 Sep 2011 1,200 1,600 - - Preferred Convertible Exchangeable Stock 6%
Marxe W Austin Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2011 500,000 3,456,900 - - Common Stock
Marxe W Austin Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2011 650,000 2,806,900 - - Common Stock
Spiro Rombotis Director, President & C.E.O. 13 Sep 2011 12,000 579,430 - - Common Stock, $0.001 par value per share
Spiro Rombotis Director, President & C.E.O. 13 Sep 2011 400 400 - - Preferred Stock, $0.001 par value per share
Spiro Rombotis Director, President & C.E.O. 22 Aug 2011 9,232 567,430 - - Common Stock, $0.001 par value per share
Marxe W Austin Ten Percent Owner Other type of transaction at price $ 0.00 per share. 07 Jul 2011 2,053,450 0 - - Options
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 25,000 25,000 - - Option
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 35,000 35,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 50,000 50,000 - - Option
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 25,000 25,000 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2011 50,000 50,000 - - Option
Marxe W Austin Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 May 2011 100,000 4,006,900 - - Common Stock
Marxe W Austin Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 May 2011 50,000 3,956,900 - - Common Stock
Paul McBarron Director, EVP, Finance, CFO, COO 10 Dec 2010 75,000 75,000 - - Option
Spiro Rombotis Director, President & C.E.O. 10 Dec 2010 75,000 75,000 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2010 62,500 62,500 - - Option
Robert Sosnowski VP, Marketing & Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2010 40,000 40,000 - - Option
Marxe W Austin Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Nov 2010 142,000 4,106,900 - - Common Stock
Marxe W Austin Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Nov 2010 58,000 4,248,900 - - Common Stock
Marxe W Austin Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Oct 2010 183,982 4,306,900 - - Common Stock
Robert Sosnowski VP, Sales & Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2010 10,000 10,000 - - Common Stock, $0.001 par value per share
Robert Sosnowski VP, Sales & Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 May 2010 10,000 0 - - Common Stock, $0.001 par value per share
Robert Sosnowski VP, Sales & Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2010 10,000 90,000 - - Option
Spiro Rombotis Director, President & C.E.O. 23 Apr 2010 8,350 483,198 - - Common Stock, $0.001 par value per share
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2010 25,000 25,000 - - Option
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2010 35,000 35,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2010 50,000 50,000 - - Option
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2010 25,000 25,000 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2010 50,000 50,000 - - Option
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2009 25,000 25,000 - - Option
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2009 35,000 35,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2009 50,000 50,000 - - Option
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2009 25,000 25,000 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2009 50,000 50,000 - - Option
Spiro Rombotis Director, President & C.E.O. 02 Dec 2008 3,000 441,548 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 19 Nov 2008 8,000 437,648 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 19 Nov 2008 900 438,548 - - Common Stock, par value $0.001 per share
Paul McBarron Director, E.V.P., Finance & C.O.O. 18 Nov 2008 50,000 126,054 - - Common Stock, par value $0.001 per share
Paul McBarron Director, E.V.P., Finance & C.O.O. 18 Nov 2008 150,000 150,000 - - Option
Spiro Rombotis Director, President & C.E.O. 18 Nov 2008 150,000 150,000 - - Option
Spiro Rombotis Director, President & C.E.O. 18 Nov 2008 50,000 50,000 - - Restricted Stock Units
Spiro Rombotis Director, President & C.E.O. 18 Nov 2008 50,000 479,648 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 18 Nov 2008 150,000 150,000 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2008 25,000 73,168 - - Common Stock, $0.001 par value per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2008 75,000 75,000 - - Option
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2008 50,000 50,000 - - Option
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2008 16,700 16,700 - - Restricted Stock Units
Robert Sosnowski VP, Marketing & Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2008 100,000 100,000 - - Option
Robert Sosnowski VP, Marketing & Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2008 16,700 16,700 - - Restricted Stock Units
Robert Sosnowski VP, Marketing & Sales Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2008 100,000 100,000 - - Option
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2008 356 650,538 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2008 644 1,176,810 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2008 19,033 631,505 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2008 34,431 1,142,379 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2008 71,200 560,305 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2008 128,800 1,013,579 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2008 56,957 503,348 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2008 131,836 881,743 - - Common Stock
Spiro Rombotis Director, President & C.E.O. 17 Nov 2008 2,000 412,648 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 17 Nov 2008 17,000 429,648 - - Common Stock, par value $0.001 per share
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Nov 2008 45,781 711,281 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Nov 2008 82,819 1,286,697 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Nov 2008 47,465 663,816 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Nov 2008 85,865 1,200,832 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Nov 2008 12,922 650,894 - - Common Stock
Flynn E James Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Nov 2008 23,378 1,177,454 - - Common Stock
Nicholas G. Bacopoulos None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Sep 2008 25,000 25,000 - - Option
Spiro Rombotis Director, President & C.E.O. 18 Aug 2008 100 401,748 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 18 Aug 2008 8,900 410,648 - - Common Stock, par value $0.001 per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2008 100 46,268 - - Common Stock, par value $0.001 per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2008 100 46,368 - - Common Stock, par value $0.001 per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2008 400 46,768 - - Common Stock, par value $0.001 per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2008 362 47,130 - - Common Stock, par value $0.001 per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2008 38 47,168 - - Common Stock, par value $0.001 per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2008 1,000 48,168 - - Common Stock, par value $0.001 per share
David C. U'Prichard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Jun 2008 4,700 25,006 - - Common Stock, par value $0.001 per share
David C. U'Prichard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Jun 2008 300 25,306 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 04 Jun 2008 5,000 396,648 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 04 Jun 2008 5,000 401,648 - - Common Stock, par value $0.001 per share
Paul McBarron Director, E.V.P., Finance & C.O.O. 22 May 2008 1,950 76,054 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 20 May 2008 5,000 384,648 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 20 May 2008 7,500 391,648 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 14 May 2008 10,000 374,648 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 14 May 2008 5,000 379,648 - - Common Stock, par value $0.001 per share
Collins William General Manager Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2008 10,000 10,000 - - Option
Spiro Rombotis Director, President & C.E.O. 19 Mar 2008 2,600 364,648 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 19 Mar 2008 3,200 362,048 - - Common Stock, par value $0.001 per share
John Francis Womelsdorf VP, Business Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Mar 2008 2,900 5,000 - - Common Stock, par value $0.001 per share
John Francis Womelsdorf VP, Business Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Mar 2008 2,100 2,100 - - Common Stock, par value $0.001 per share
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2008 25,000 25,000 - - Option
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2008 25,000 25,000 - - Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2008 50,000 50,000 - - Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2008 50,000 50,000 - - Option
Gordon McVie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2008 25,000 25,000 - - Option
Pierre Legault None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2008 35,000 35,000 - - Option
Gregory Reyes Senior VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2007 25,000 25,000 - - Options
Gregory Reyes Senior VP, Research Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Dec 2007 3,000 3,000 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 19 Dec 2007 1,400 357,848 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 19 Dec 2007 1,000 358,848 - - Common Stock, par value $0.001 per share
Paul McBarron Director, E.V.P., Finance & C.O.O. 06 Dec 2007 100,000 100,000 - - Option
Spiro Rombotis Director, President & C.E.O. 06 Dec 2007 200,000 200,000 - - Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2007 100,000 100,000 - - Option
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2007 50,000 50,000 - - Option
Gregory Reyes Senior VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2007 25,000 25,000 - - Options
Collins William General Manager Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Oct 2007 35,000 35,000 - - Option
Gregory Reyes Senior VP, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2007 55,000 55,000 - - Options
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2007 31,250 31,250 - - Options
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2007 33,750 33,750 - - Options
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2007 62,500 62,500 - - Options
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2007 62,500 62,500 - - Options
Gordon McVie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2007 31,250 31,250 - - Options
Pierre Legault None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2007 35,000 35,000 - - Options
Paul McBarron Director, E.V.P., Finance & C.O.O. 21 Dec 2006 100,000 100,000 - - Option
Spiro Rombotis Director, President & C.E.O. 21 Dec 2006 160,000 160,000 - - Options
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2006 80,000 80,000 - - Option
Robert Westwood V.P., Chem. & Preclin. Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2006 50,000 50,000 - - Option
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Dec 2006 50,000 50,000 - - Option
Jean Deleage Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Dec 2006 114,239 0 - - Common Stock
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2006 8,333 25,000 - - Option
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2006 40,000 40,000 - - Option
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2006 8,333 16,667 - - Option
Spiro Rombotis Director, President & C.E.O. 14 Sep 2006 100 355,148 - - Common Stock
Spiro Rombotis Director, President & C.E.O. 14 Sep 2006 1,300 356,448 - - Common Stock
David C. U'Prichard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2006 320 19,666 - - Common Stock
David C. U'Prichard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2006 320 19,986 - - Common Stock
David C. U'Prichard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2006 320 20,306 - - Common Stock
Spiro Rombotis Director, President & C.E.O. 12 Sep 2006 100 355,048 - - Common Stock
David C. U'Prichard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Sep 2006 250 19,026 - - Common Stock
David C. U'Prichard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 08 Sep 2006 320 19,346 - - Common Stock
Spiro Rombotis Director, President & C.E.O. 08 Sep 2006 300 354,848 - - Common Stock
Spiro Rombotis Director, President & C.E.O. 08 Sep 2006 100 354,948 - - Common Stock
John Banham None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Sep 2006 3,500 36,847 - - Common Stock
David C. U'Prichard None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Sep 2006 250 18,776 - - Common Stock
Spiro Rombotis Director, President & C.E.O. 06 Sep 2006 300 354,248 - - Common Stock
Spiro Rombotis Director, President & C.E.O. 06 Sep 2006 300 354,548 - - Common Stock
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2006 8,334 8,334 - - Option
John Francis Womelsdorf VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2006 8,334 8,334 - - Option
John Banham None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2006 18,750 18,750 - - Common Stock Option
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2006 26 26,250 - - Common Stock Option
David C. U'Prichard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2006 37,500 37,500 - - Common Stock Option
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2006 37,500 37,500 - - Common Stock Option
Paul McBarron Director, E.V.P., Finance & C.O.O. 14 Jun 2006 63,680 63,680 - - Common Stock Option
Gordon McVie None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2006 18,750 18,750 - - Common Stock Option
Spiro Rombotis Director, President & C.E.O. 14 Jun 2006 97,834 97,834 - - Common Stock Option
Robert Jackson S.V.P. & Chief Scientific Offi Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2006 63,606 63,606 - - Common Stock Option
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2006 48,967 48,967 - - Common Stock Option
Robert Westwood V.P., Chem. & Preclin. Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2006 49,144 49,144 - - Common Stock Option
Spiro Rombotis Director, President & C.E.O. 17 Apr 2006 100 353,948 - - Common Stock
John Banham None Other type of transaction at price $ 0.00 per share. 27 Mar 2006 33,347 33,347 - - Common Stock, par value $0.001 per share
David C. U'Prichard None Other type of transaction at price $ 0.00 per share. 27 Mar 2006 18,526 18,526 - - Common Stock, par value $0.001 per share
Paul McBarron Director, E.V.P., Finance & C.O.O. 27 Mar 2006 74,104 74,104 - - Common Stock, par value $0.001 per share
Spiro Rombotis Director, President & C.E.O. 27 Mar 2006 353,848 353,848 - - Common Stock, par value $0.001 per share
Robert Jackson S.V.P. & Chief Scientific Offi Other type of transaction at price $ 0.00 per share. 27 Mar 2006 64,841 64,841 - - Common Stock, par value $0.001 per share
Judy Chiao V.P., Clin. Dev. & Reg. Aff. Other type of transaction at price $ 0.00 per share. 27 Mar 2006 48,168 46,168 - - Common Stock, par value $0.001 per share
Robert T. Nelsen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 10,000 10,000 - - Stock Option (Right To Buy)
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 10,000 10,000 - - Director (Stock Option Right to Buy)
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 2,500 12,500 - - Director (Stock Option Right to Buy)
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 2,500 15,000 - - Director (Stock Option Right to Buy)
Stephen N. Wertheimer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 10,000 10,000 - - Director (Stock Option Right to Buy)
Stephen N. Wertheimer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 2,500 12,500 - - Director (Stock Option Right to Buy)
Jean Deleage None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 10,000 10,000 - - Director (Stock Option Right to Buy)
Jean Deleage None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 2,500 12,500 - - Director (Stock Option Right to Buy)
Peter Langecker None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 10,000 10,000 - - Director (Stock Option Right to Buy)
Peter Langecker None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 2,500 12,500 - - Director (Stock Option Right to Buy)
Peter Langecker None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 2,500 15,000 - - Director (Stock Option Right to Buy)
Robert M. Williams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2005 10,000 10,000 - - Director (Stock Option Right to Buy)
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2005 10,000 10,000 - - Director Stock Option (Right to Buy)
Christopher S. Henney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2005 200,000 200,000 - - Director Stock Option (Right to Buy)
Peter Langecker None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Feb 2005 3,000 5,000 - - Common
Robert L. Kirkman Chief Business Officer and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2005 40,000 40,000 - - Employee Stock Option (Right to Buy)
Ronald J. Berenson Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2005 100,000 100,000 - - Employee Stock Option (Right to Buy)
Mark Frohlich Medical Director and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2005 20,000 20,000 - - Employee Stock Option (Right to Buy)
Steve Pegg SVP Finance, Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2005 20,000 20,000 - - Employee Stock Option (Right to Buy)
Stewart Craig COO and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2005 40,000 40,000 - - Employee Stock Option (Right to Buy)
Bonyhadi L Mark Vice President, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2005 25,000 25,000 - - Employee Stock Option (Right to Buy)
Black S Joanna VP and General Counsel, Secret Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2005 12,500 12,500 - - Employee Stock Option (Right to Buy)
Romel A Lawrence VP Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2005 5,000 5,000 - - Employee Stock Option (Right to Buy)
Robert M. Williams None Gift of securities by or to the insider at price $ 0.00 per share. 15 Dec 2004 1,156 45,700 - - Common
Robert L. Kirkman Chief Business Officer and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2004 40,000 40,000 - - Employee Stock Option (Right to Buy)
Ronald J. Berenson Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2004 100,000 100,000 - - Employee Stock Option (Right to Buy)
Mark Frohlich Medical Director and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2004 20,000 20,000 - - Employee Stock Option (Right to Buy)
Steve Pegg SVP Finance, Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2004 20,000 20,000 - - Employee Stock Option (Right to Buy)
Stewart Craig COO and VP Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2004 40,000 40,000 - - Employee Stock Option (Right to Buy)
Bonyhadi L Mark Vice President, Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2004 25,000 25,000 - - Employee Stock Option (Right to Buy)
Black S Joanna VP and General Counsel, Secret Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2004 12,500 12,500 - - Employee Stock Option (Right to Buy)
Romel A Lawrence VP Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2004 5,000 5,000 - - Employee Stock Option (Right to Buy)
Stephen N. Wertheimer None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Nov 2004 103,500 103,500 - - 6% Convertible Exchangeable Preferred Stock
Jean Deleage Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Nov 2004 97,766 97,766 - - 6% Convertible Exchangeable Preferred Stock
Jean Deleage Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Nov 2004 2,234 2,234 - - 6% Convertible Exchangeable Preferered Stock
Robert T. Nelsen Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 Oct 2004 200,000 851,060 - - 6% Convertible Exchangeable Preferred Stock
Keith L. Crandell Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 Oct 2004 200,000 851,060 - - 6% Convertible Exchangeable Preferred Stock
Steven B. Lazarus Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 Oct 2004 200,000 851,060 - - 6% Convertible Exchangeable Preferred Stock
Clinton Bybee Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 Oct 2004 200,000 851,060 - - 6% Convertible Exchangeable Preferred Stock
Daniel K. Spiegelman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2004 10,000 10,000 - - Director Stock Option (Right to Buy)
Romel A Lawrence VP Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2004 30,000 30,000 - - Employee Stock Option (Right to Buy)
Peter Langecker None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2004 1,000 1,000 - - Common
Peter Langecker None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2004 1,000 2,000 - - Common
Ronald J. Berenson Director, President & C.E.O. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Apr 2004 27,272 430,939 - - Common Stock
Ronald J. Berenson Director, President & C.E.O. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Apr 2004 27,272 0 - - Employee Stock Option (right to buy)
Robert L. Kirkman Chief Business Officer & V.P. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2004 40,000 40,000 - - Employee Stock Option (right to buy)
Ronald J. Berenson Director, President & C.E.O. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2004 45,000 45,000 - - Employee Stock Option (right to buy)
Mark Frohlich Medical Director and V.P. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2004 15,000 15,000 - - Employee Stock Option (right to buy)
Steve Pegg S.V.P. of Finance & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2004 20,000 20,000 - - Employee Stock Option (right to buy)
Stewart Craig C.O.O. & Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2004 20,000 20,000 - - Employees Stock Option (right to buy)
Bonyhadi L Mark V.P , Research Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2004 5,000 5,000 - - Employee Stock Option (right to buy)
Black S Joanna General Counsel, V.P. & Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Apr 2004 15,000 15,000 - - Employee Stock Option (right to buy)
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 354,837 0 - - 6% Convertible Promissory Notes
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 899,104 0 - - Series F Convertible Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 89,002 0 - - Warrants to purchase Common Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 1,866,771 1,866,771 - - Common Stock
Robert T. Nelsen Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Mar 2004 187,500 2,054,271 - - Common Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 789,469 0 - - Series A Convertible Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 2,045,454 0 - - Series B Convertible Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 1,119,265 0 - - Series C Convertible Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 1,321,942 0 - - Series D Convertible Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 935,251 0 - - Series E Convertible Preferred Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 50,237 0 - - Warrants to purchase Series A Convertible Preferred
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 26,918 0 - - Warrants to purchase Common Stock
Robert T. Nelsen Director, Ten Percent Owner 19 Mar 2004 92,580 0 - - Warrants to purchase Common Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 1,119,265 0 - - Series C Convertible Preferred Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 1,321,942 0 - - Series D Convertible Preferred Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 935,251 0 - - Series E Convertible Preferred Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 50,237 0 - - Warrants to purchase Series A Convertible Preferred Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 26,918 0 - - Warrants to purchase Common Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 92,580 0 - - Warrants to purchase Common Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 354,837 0 - - 6% Convertible Promissory Notes
Keith L. Crandell Ten Percent Owner 19 Mar 2004 899,104 0 - - Series F Convertible Preferred Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 89,002 0 - - Warrants to purchase Common Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 1,866,771 1,866,771 - - Common Stock
Keith L. Crandell Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Mar 2004 187,500 2,054,271 - - Common Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 789,469 0 - - Series A Convertible Preferred Stock
Keith L. Crandell Ten Percent Owner 19 Mar 2004 2,045,454 0 - - Series B Convertible Preferred Stock
Stephen N. Wertheimer None 19 Mar 2004 106,632 0 - - Convertible Promissory Note
Stephen N. Wertheimer None 19 Mar 2004 326,620 0 - - Series C Convertible Preferred Stock
Stephen N. Wertheimer None 19 Mar 2004 52,004 0 - - Series D Convertible Preferred Stock
Stephen N. Wertheimer None 19 Mar 2004 54,836 0 - - Series E Convertible Preferred Stock
Stephen N. Wertheimer None 19 Mar 2004 29,649 0 - - Common Stock Warrant (Right to Buy)
Stephen N. Wertheimer None 19 Mar 2004 4,622 0 - - Common Stock Warrant (Right to Buy)
Stephen N. Wertheimer None 19 Mar 2004 106,632 0 - - Common Stock
Stephen N. Wertheimer None 19 Mar 2004 326,620 0 - - Common Stock
Stephen N. Wertheimer None 19 Mar 2004 52,004 0 - - Common Stock
Stephen N. Wertheimer None 19 Mar 2004 54,836 0 - - Common Stock
Stephen N. Wertheimer None 19 Mar 2004 29,649 0 - - Common Stock
Stephen N. Wertheimer None 19 Mar 2004 4,622 574,363 - - Common Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 1,866,771 1,866,771 - - Common Stock
Steven B. Lazarus Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Mar 2004 187,500 2,054,271 - - Common Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 789,469 0 - - Series A Convertible Preferred Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 2,045,454 0 - - Series B Convertible Preferred Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 1,119,265 0 - - Series C Convertible Preferred Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 1,321,942 0 - - Series D Convertible Preferred Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 935,251 0 - - Series E Convertible Preferred Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 50,237 0 - - Warrants to purchase Series A Convertible Preferred Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 26,918 0 - - Warrants to purchase Common Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 92,580 0 - - Warrants to purchase Common Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 354,837 0 - - 6% Convertible Promissory Notes
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 899,104 0 - - Series F Convertible Preferred Stock
Steven B. Lazarus Ten Percent Owner 19 Mar 2004 89,002 0 - - Warrants to purchase Common Stock
Jean Deleage None 19 Mar 2004 1,894,737 0 - - Series A Convertible Preferred Stock
Jean Deleage None 19 Mar 2004 805,281 0 - - Series B Convertible Preferred Stock
Jean Deleage None 19 Mar 2004 971,331 0 - - Series C Convertible Preferred Stock
Jean Deleage None 19 Mar 2004 584,547 0 - - Series D Convertible Preferred Stock
Jean Deleage None 19 Mar 2004 359,712 0 - - Series E Convertible Preferred Stock
Jean Deleage None 19 Mar 2004 261,312 0 - - Common Stock Warrants (right to buy)
Jean Deleage None 19 Mar 2004 261,312 0 - - Preferred Stock Warrants (right to buy)
Jean Deleage None 19 Mar 2004 261,312 0 - - 6% Convertible Promissory Note
Jean Deleage None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Mar 2004 125,000 0 - - Common Stock
Jean Deleage None 19 Mar 2004 1,017,400 1,142,400 - - Common Stock
Ronald J. Berenson Director, President & C.E.O. 19 Mar 2004 10,526 403,667 - - Common Stock
Ronald J. Berenson Director, President & C.E.O. 19 Mar 2004 10,526 0 - - Series A Convertible Preferred Stock
Robert E. Curry None 19 Mar 2004 10,670 0 - - Common Stock
Robert E. Curry None 19 Mar 2004 478,466 0 - - Common Stock
Robert E. Curry None 19 Mar 2004 99,172 0 - - Common Stock
Robert E. Curry None 19 Mar 2004 207,805 0 - - Common Stock
Robert E. Curry None 19 Mar 2004 58,861 0 - - Common Stock
Robert E. Curry None 19 Mar 2004 64,741 0 - - Common Stock
Robert E. Curry None 19 Mar 2004 660 0 - - Common Stock
Robert E. Curry None 19 Mar 2004 35,360 0 - - Common Stock
Robert E. Curry None 19 Mar 2004 5,229 960,964 - - Common Stock
Robert E. Curry None 19 Mar 2004 10,670 0 - - Convertible Promissory Note
Robert E. Curry None 19 Mar 2004 478,466 0 - - Series A Convertible Preferred Stock
Robert E. Curry None 19 Mar 2004 99,172 0 - - Series B Convertible Preeferred Stock
Robert E. Curry None 19 Mar 2004 207,805 0 - - Series C Convertible Preferred Stock
Robert E. Curry None 19 Mar 2004 58,861 0 - - Series D Convertible Preferred Stock
Robert E. Curry None 19 Mar 2004 64,741 0 - - Series E Convertible Preferred Stock
Robert E. Curry None 19 Mar 2004 660 0 - - Series F Convertible Preferred Stock
Robert E. Curry None 19 Mar 2004 35,360 0 - - Common Stock Warrant (Right to Buy)
Robert E. Curry None 19 Mar 2004 5,229 0 - - Common Stock Warrant (Right to Buy)
Clinton Bybee Ten Percent Owner 19 Mar 2004 26,918 0 - - Warrants to purchase Common Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 92,580 0 - - Warrants to purchase Common Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 354,837 0 - - 6% Convertible Promissory Notes
Clinton Bybee Ten Percent Owner 19 Mar 2004 899,104 0 - - Series F Convertible Preferred Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 89,002 0 - - Warrants to purchase Common Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 1,866,771 1,866,771 - - Common Stock
Clinton Bybee Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Mar 2004 187,500 2,054,271 - - Common Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 789,469 0 - - Series A Convertible Preferred Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 2,045,454 0 - - Series B Convertible Preferred Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 1,119,265 0 - - Series C Convertible Preferred Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 1,321,942 0 - - Series D Convertible Preferred Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 935,251 0 - - Series E Convertible Preferred Stock
Clinton Bybee Ten Percent Owner 19 Mar 2004 50,237 0 - - Warrants to purchase Series A Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures